Back to Pediatrics
Pediatricsvoriginal_1987Evidence-Based

Lansky Play-Performance Scale for Pediatric Functional Status

Assesses functional status in pediatric patients (under 16 years) using parent description of child's play activity and daily function, primarily used in pediatric oncology to evaluate treatment response and disease progression

Clinical Input Parameters

points
Clinical Assessment
Awaiting Parameters
lansky performance score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Lansky Play-Performance Scale for Pediatric Functional Status is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within pediatrics.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Direct assessment based on clinical observation and parent report of child's functional status and play activity level

Clinical Pearls & Practice Notes

  • Designed for children under 16 years of age
  • Primarily used in pediatric oncology settings
  • Parent/caregiver input is essential for accurate assessment
  • Should be assessed regularly to monitor disease progression and treatment response
  • Scores ≥80 generally indicate ability to participate in normal activities
  • Scores 50-70 suggest moderate functional impairment requiring support
  • Scores <50 indicate severe functional limitation requiring extensive care
  • May be used for clinical trial eligibility determination
  • Consider combining with other functional assessments for comprehensive evaluation
  • Cultural and age-appropriate play activities should be considered
  • Assessment should reflect child's typical performance over recent period
  • Not intended as sole criterion for major treatment decisions

Evidence & Literature Citations

  1. Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR. The measurement of performance in childhood cancer patients. Cancer. 1987 Oct 1;60(7):1651-6.
  2. Lansky LL, Cairns NU, Clark GM, Lowman J, Miller L, Trueworthy R. Childhood leukemia: nonrandomized therapy with adriamycin. Cancer. 1975 Jan;35(1):306-17.
  3. Steineck A, Bradford MC, Erickson JM, Johnson G, Klages KL, Words B, et al. Toward the development of a play performance scale for children (PPSC). Cancer. 1987 Oct 1;60(7):1651-6.
  4. Chung OK, Li HC, Chiu SY, Ho KY, Lopez V. The impact of cancer and its treatment on physical activity levels and behavior in Hong Kong Chinese childhood cancer survivors. Cancer Nurs. 2014 May-Jun;37(3):E43-51.

Score Interpretation Ranges

Unresponsive0 – 0 pts

Completely unresponsive

Severe Disability10 – 10 pts

Does not play; does not get out of bed

Major Disability20 – 20 pts

Sleeping often; play entirely limited to very passive activities

Moderate-Severe Disability30 – 30 pts

Bedbound; needing assistance even for quiet play

Moderate Disability40 – 40 pts

Mainly in bed; participates in quiet activities

Mild-Moderate Disability50 – 60 pts

Up and around but with limited activity

Mild Disability70 – 70 pts

Greater restriction of play and less time spent in play activity

Minimal Disability80 – 90 pts

Active but with some limitations

Normal Function100 – 100 pts

Fully active, normal

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.